Red X iconGreen tick iconYellow tick icon
MBChB, FRACP, DM(Southampton), FAAAAI, FRCP(London), DSc(Otago), FFOM(Hon)

Contact details

Tel +64 4 805 0230


Richard Beasley teaches in 5th Year (General Medicine and Subspecialties) and 6th Year medical student programmes. His interests are respiratory medicine – clinical and epidemiology.

He is also the Director of the Medical Research Institute of New Zealand (an independent medical research organisation).


Travers J, Marsh S, Shirtcliffe P, Beasley R. External validity of pharmaceutical trials in asthma and chronic obstructive pulmonary disease. In: The Lancet. Treating Individuals: From randomised trials to personalised medicine. Rothwell PM (ed). Elsevier Limited 2007, pp 131-5.

Beasley R, Patel M, Perrin K, O'Driscoll BR. High concentration oxygen therapy in COPD. Lancet 2011; 378: 969-70.

Beasley R, Perrin K, Weatherall M, Wijesinghe M. Call for withdrawal of LABA single inhaler therapy in asthma. Lancet 2010; 376: 750-1.

Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet 2009; 374: 670-2.

Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW, Montefort S, Stewart A for the ISAAC Phase Three Study Group. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039-48.

Beasley R, McNaughton A, Robinson G. New look at the oxyhaemoglobin dissociation curve. Lancet 2006; 367: 1124-6.

Hughes R, Goldkorn A, Masoli M, Weatherall M, Burgess C, Beasley R. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in the treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet 2003; 361: 2114-7.

Hughes R, Hopkins RJ, Hill S, Weatherall M, Van de Water N, Nowitz M, Milne D, Ayling J, Wilsher M, Beasley R. Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) Study. Lancet 2003; 362: 2039-44.

Beasley R, Keil U, von Mutius E, Pearce N, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Björkstén B, Burr ML, Clayton TO, Crane J, Ellwood P, Lai C, Mallol J, Martinez FD, Mitchell EA, Montefort S, Robertson C, Shah JR, Sibbald B, Stewart AW, Strachan D, Weiland SK, Williams HC. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Lancet 1998; 351: 1225-32.

Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 1995; 345: 41-4.

Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: A case control study. Lancet 1989; 1(8644): 917-22.

Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1(8637): 520-4.

Beasley R, Rafferty P, Holgate S. Benzalkonium chloride and bronchoconstriction. Lancet 1986; 2: 1227.

Back to top